1
|
Shrestha S, Stopka TJ, Hughto JMW, Case P, Palacios WR, Reilly B, Green TC. LatinX harm reduction capital, medication for opioid use disorder, and nonfatal overdose: A structural equation model analysis among people who use drugs in Massachusetts. Drug Alcohol Depend 2024; 259:111293. [PMID: 38643530 DOI: 10.1016/j.drugalcdep.2024.111293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 04/02/2024] [Accepted: 04/03/2024] [Indexed: 04/23/2024]
Abstract
BACKGROUND We introduce the concept of harm reduction capital (HRCap) as the combination of knowledge, resources, and skills related to substance use risk reduction, which we hypothesize to predict MOUD use and opioid overdose. In this study, we explored the interrelationships between ethnicity, HRCap, nonfatal overdose, and MOUD use among PWUD. METHODS Between 2017 and 2019, people who currently or in the past used opioids and who lived in Massachusetts completed a one-time survey on substance use history, treatment experiences, and use of harm reduction services. We fit first-order measurement constructs for positive and negative HRCap (facilitators and barriers). We used generalized structural equation models to examine the inter-relationships of the latent constructs with LatinX self-identification, past year overdose, and current use of MOUD. RESULTS HRCap barriers were positively associated with past-year overdose (b=2.6, p<0.05), and LatinX self-identification was inversely associated with HRCap facilitators (b=-0.49, p<0.05). There was no association between overdose in the past year and the current use of MOUD. LatinX self-identification was positively associated with last year methadone treatment (b=0.89, p<0.05) but negatively associated with last year buprenorphine treatment (b=-0.68, p<0.07). Latinx PWUD reported lower positive HRCap than white non-LatinX PWUD and had differential utilization of MOUD. CONCLUSION Our findings indicate that a recent overdose was not associated with the current use of MOUD, highlighting a severe gap in treatment utilization among individuals at the highest risk. The concept of HRCap and its use in the model highlight substance use treatment differences, opportunities for intervention, and empowerment.
Collapse
Affiliation(s)
- Shikhar Shrestha
- Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States.
| | - Thomas J Stopka
- Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States
| | - Jaclyn M W Hughto
- Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, United States; Department of Epidemiology, Brown University School of Public Health, Providence, RI, United States; Center for Health Promotion and Health Equity, Brown University, Providence, RI, United States
| | - Patricia Case
- Bouvé College of Health Sciences, Northeastern University, Boston, MA, United States
| | - Wilson R Palacios
- School of Criminology & Justice Studies, University of Massachusetts, Lowell, MA, United States
| | - Brittni Reilly
- Massachusetts Department of Public Health, Bureau of Substance Addiction Services, Boston, MA, United States
| | - Traci C Green
- Department of Epidemiology, Brown University School of Public Health, Providence, RI, United States; Opioid Policy Research Collaborative, Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States; Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, United States
| |
Collapse
|
2
|
Kusmaul N, Cheon JH, Gibson A. A Policy Mapping Analysis of the U.S. Congressional Approach to Medical Aid-in-Dying. OMEGA-JOURNAL OF DEATH AND DYING 2023; 88:139-156. [PMID: 34490818 DOI: 10.1177/00302228211043694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This study examines the goals of medical aid-in-dying (MAID) legislation introduced to the US Congress from 1994-2020 using a policy mapping analysis approach. Using congress.gov, we identified 98 bills, 23 bills were analyzed in this study. Most of the bills aimed to restrict the use of federal funds, to regulate the drugs commonly used for MAID, to prohibit the development of policies or practices supporting MAID, and to regulate practitioners' roles in MAID. In practice, these bills would limit patient access to MAID by restricting drugs, funds, health care services, legal assistance, policy, and research. These findings suggest there lacks congressional support for MAID, even though polls of the public are divided yet favorable. Policymakers who support MAID should consider affirmative policies that 1) prevent MAID policies from discriminating against vulnerable groups, 2) support funding to study the use of MAID, and 3) build avenues to allow all qualified people to access MAID in places where it is legal.
Collapse
Affiliation(s)
- Nancy Kusmaul
- School of Social Work University of Maryland Baltimore County, Baltimore, Maryland, United States
| | - Ji Hyang Cheon
- School of Social Work University of Maryland Baltimore, Baltimore, Maryland, United States
| | - Allison Gibson
- College of Social Work University of Kentucky, Baltimore, Maryland, United States
| |
Collapse
|
3
|
Birkenmaier J, Janssen A. A Policy Mapping Analysis of Goals Related to Bank Accounts in Federal Legislative Proposals. JOURNAL OF POLICY PRACTICE AND RESEARCH 2022. [PMCID: PMC8380113 DOI: 10.1007/s42972-021-00037-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
The US struggles to fully bank the unbanked and underbanked populations. This paper examined the policy landscape around these efforts by exploring the following research questions: (1) What policy goals that may impact the availability of low-cost, basic bank accounts that have been introduced in Congress as legislation? (2) How far in the legislative process did the legislation advance? (3) What populations did these proposed laws target? and (4) What related policy goals were pursued most ardently over the past 20 years? We conducted a policy mapping content analysis of all bank account-related bills (N = 32) proposed in Congress between 1999 and 2020 (May) (106th–116th Congresses). Two researchers independently coded basic characteristics (e.g., type, status, sponsorship), focal populations, and illustrative mechanisms for policy goals using a taxonomy developed by the researchers. Researchers compared codes and addressed discrepancies through consensus. New codes were created as needed. Goals appearing most often were expanding access to bank accounts (81.2%), increasing consumer protection (81.2%), and reducing costs of basic accounts (78.2%). Increasing consumer disclosure (37.5%) and expanding the type of institutions that offer basic accounts (9.4%) were addressed infrequently in the legislation. No legislation addressed the policy goal of expanding account access in minority populations and communities. Explicit attention toward unbanked and underbanked households, racial/ethnic minorities, and other vulnerable populations was rare. This study represents the first systematic analysis of key features of the US congressional response to the problem of affordability and accessibility of bank accounts. Legislative attention to the policy goals of expanding access and types of institutions that offer accounts is needed.
Collapse
|
4
|
McNeil R, Jauffret-Roustide M, Hansen H. Reducing Drug-Related Harms and Promoting Health Justice Worldwide During and After COVID-19: An AJPH Supplement. Am J Public Health 2022; 112:S95-S98. [PMID: 35349319 PMCID: PMC8965184 DOI: 10.2105/ajph.2022.306804] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/22/2022] [Indexed: 11/04/2022]
Affiliation(s)
- Ryan McNeil
- Ryan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue
| | - Marie Jauffret-Roustide
- Ryan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue
| | - Helena Hansen
- Ryan McNeil is with the Program in Addiction Medicine, Yale University, New Haven, CT. Marie Jauffret-Roustide is with Centre d'Études des Mouvements Sociaux (Inserm U1276/CNRS UMR 8044/EHESS), Paris, France, and the Social Science, Drugs and Society Program, Paris, France. Helena Hansen is with the Research Theme in Health Equity Research and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. The authors are also Guest Editors for this supplement issue
| |
Collapse
|
5
|
Nguemeni Tiako MJ, Netherland J, Hansen H, Jauffret-Roustide M. Drug Overdose Epidemic Colliding With COVID-19: What the United States Can Learn From France. Am J Public Health 2022; 112:S128-S132. [PMID: 35349315 PMCID: PMC8965177 DOI: 10.2105/ajph.2022.306763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/23/2022] [Indexed: 11/04/2022]
Affiliation(s)
- Max Jordan Nguemeni Tiako
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Jules Netherland
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Helena Hansen
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| | - Marie Jauffret-Roustide
- Max Jordan Nguemeni Tiako is a resident physician in internal medicine at Brigham and Women's Hospital, Boston, MA. Jules Netherland is the managing director of the Department of Research and Academic Engagement for the Drug Policy Alliance, New York, NY. Helena Hansen is professor and chair of Research Theme in Translational Social Science and Health Equity, as well as associate director of the Center for Social Medicine at David Geffen School of Medicine, University of California, Los Angeles. Marie Jauffret-Roustide is a research fellow at the Institut National de la Santé et de la Recherche Médicale in Paris, France, and affiliate scientist at the British Columbia Centre on Substance Use, Vancouver, Canada. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue
| |
Collapse
|
6
|
Weiss M, Zoorob M. Political frames of public health crises: Discussing the opioid epidemic in the US Congress. Soc Sci Med 2021; 281:114087. [PMID: 34102424 DOI: 10.1016/j.socscimed.2021.114087] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Revised: 04/10/2021] [Accepted: 05/25/2021] [Indexed: 01/20/2023]
Abstract
When and how do politicians talk about public health crises? Using evidence from the opioid crisis in the United States, this paper assembles and analyzes novel data on Congressional statements to explore the conditions under which politicians (1) issue public statements about opioids and (2) frame the opioid crisis as a predominantly public health or law enforcement problem. We examined 3.8 million Congressional floor speeches and 111,000 public statements to identify (1) floor speeches about drug crises in the 97th to 114th Congresses (1981-2017) and (2) public statements about the opioid crisis in the 116th Congress (2019-2020). Moderate ideology, women, greater overdose deaths, and larger white populations are associated with significantly higher frequencies of opioid statements. Using a dictionary-based text analysis approach, we find that ideologically liberal and African American legislators are more likely to use public health framing, while ideologically conservative members are more likely to use law enforcement framing and refer to national borders or foreign countries in opioid statements. Democrats/liberals more often referenced medication treatment for opioids. These findings imply two broader conclusions about the nature of political discourse in public health crises. First, that political extremists are least likely to talk about opioids suggests that increasing partisan polarization may result in less discussion, emphasis, and expertise in public health issues. Second, the tenor of discourse about opioids and other public health crises is likely to change with partisan electoral waves, potentially hindering long term planning of public health capacity.
Collapse
Affiliation(s)
| | - Michael Zoorob
- Department of Government, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
7
|
Woolhandler S, Himmelstein DU, Ahmed S, Bailey Z, Bassett MT, Bird M, Bor J, Bor D, Carrasquillo O, Chowkwanyun M, Dickman SL, Fisher S, Gaffney A, Galea S, Gottfried RN, Grumbach K, Guyatt G, Hansen H, Landrigan PJ, Lighty M, McKee M, McCormick D, McGregor A, Mirza R, Morris JE, Mukherjee JS, Nestle M, Prine L, Saadi A, Schiff D, Shapiro M, Tesema L, Venkataramani A. Public policy and health in the Trump era. Lancet 2021; 397:705-753. [PMID: 33581802 DOI: 10.1016/s0140-6736(20)32545-9] [Citation(s) in RCA: 60] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 09/22/2020] [Accepted: 11/13/2020] [Indexed: 12/12/2022]
Affiliation(s)
- Steffie Woolhandler
- Cambridge Health Alliance, Harvard University, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA
| | - David U Himmelstein
- School of Urban Public Health, City University of New York at Hunter College, New York, NY, USA; Cambridge Health Alliance, Harvard University, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA.
| | - Sameer Ahmed
- Harvard Immigration and Refugee Clinical Program, Harvard Law School, Harvard University, Boston, MA, USA
| | - Zinzi Bailey
- Medical Oncology Division, University of Miami Miller School of Medicine, Miami, FL, USA
| | - Mary T Bassett
- Francois-Xavier Bagnoud Center for Health and Human Rights, Harvard University, Boston, MA, USA
| | | | - Jacob Bor
- School of Public Health, Boston University, Boston, MA, USA
| | - David Bor
- Cambridge Health Alliance, Harvard University, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA
| | - Olveen Carrasquillo
- Division of General Internal Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
| | | | | | - Samantha Fisher
- Program for Global Public Health and the Common Good, Boston College, Chestnut Hill, MA, USA
| | - Adam Gaffney
- Cambridge Health Alliance, Harvard University, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA
| | - Sandro Galea
- School of Public Health, Boston University, Boston, MA, USA
| | | | - Kevin Grumbach
- Department of Family and Community Medicine, University of California, San Francisco, CA, USA
| | - Gordon Guyatt
- Department of Health Research Methods, Evidence & Impact and Department of Medicine, McMaster University, Hamilton, ON, Canada
| | - Helena Hansen
- Research Theme in Translational Social Science and Health Equity, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
| | - Philip J Landrigan
- Program for Global Public Health and the Common Good, Boston College, Chestnut Hill, MA, USA
| | | | - Martin McKee
- Department of Health Services Research & Policy, London School of Hygiene & Tropical Medicine, London, UK
| | - Danny McCormick
- Cambridge Health Alliance, Harvard University, Boston, MA, USA; Harvard Medical School, Harvard University, Boston, MA, USA
| | - Alecia McGregor
- Department of Community Health, Tufts University, Medford, MA, USA
| | - Reza Mirza
- Department of Medicine, University of Toronto, Toronto, ON, Canada
| | - Juliana E Morris
- Harvard Medical School, Harvard University, Boston, MA, USA; Department of Medicine and Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA
| | - Joia S Mukherjee
- Harvard Medical School, Harvard University, Boston, MA, USA; Partners in Health, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | - Marion Nestle
- Department of Nutrition and Food Studies, New York University, New York, NY, USA
| | - Linda Prine
- Department of Family and Community Medicine, Mount Sinai School of Medicine, New York, NY, USA
| | - Altaf Saadi
- Harvard Medical School, Harvard University, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA
| | - Davida Schiff
- Harvard Medical School, Harvard University, Boston, MA, USA; Division of General Academic Pediatrics, MassGeneral Hospital for Children, Boston, MA, USA
| | - Martin Shapiro
- Department of Medicine, Weill Cornell Medical College, New York, NY, USA
| | - Lello Tesema
- Department of Public Health, Los Angeles County, Los Angeles, CA, USA
| | - Atheendar Venkataramani
- Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
8
|
Nelson KL, Purtle J. Factors associated with state legislators' support for opioid use disorder parity laws. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2020; 82:102792. [PMID: 32540516 PMCID: PMC7483853 DOI: 10.1016/j.drugpo.2020.102792] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 04/30/2020] [Accepted: 05/15/2020] [Indexed: 12/23/2022]
Abstract
BACKGROUND In the United States, state behavioral health parity laws play a crucial role in ensuring equitable insurance coverage and access to substance use disorder treatment and services for people that need them. State legislators have the exclusive authority to adopt these laws. The purpose of this study was to identify legislator beliefs independently associated with "strong support" for opioid use disorder (OUD) parity. METHODS Data were from a 2017 cross-sectional, state-stratified, multi-modal survey of state legislators (N = 475). The dependent variable was "strong support" for OUD parity. Primary independent variables were beliefs about state parity laws. Bivariate analyses and mixed effects logistic regression were conducted. RESULTS Legislators who "strongly supported" OUD parity were significantly more likely than legislators who did not "strongly support" OUD parity to be female (64.1% vs. 46.5%, p<.001) , Democrat (76.2% vs. 29.3%, p<.001), and have liberal, compared to conservative, ideology (85.6% vs. 27.1%, p<.001). After adjusting for legislator demographics and state-level covariates, beliefs such as agreeing that state parity laws do not increase health insurance premium costs (aOR=6.77, p<.01) and that substance use disorder treatments can be effective (aOR=5.00, p<.001) remained associated with "strong support" for OUD parity. These state legislators' beliefs were more strongly associated with "strong support" for OUD parity than political party, ideology, and other demographic and state-level characteristics. CONCLUSIONS Dissemination materials and communication strategies to cultivate support for OUD parity laws among state legislators should focus on the fiscal impacts of parity laws and the effectiveness of substance use disorder treatments.
Collapse
Affiliation(s)
- Katherine L Nelson
- Department of Health Management and Policy, Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States; Urban Health Collaborative, Drexel University, Philadelphia, PA, United States.
| | - Jonathan Purtle
- Department of Health Management and Policy, Dornsife School of Public Health, Drexel University, Philadelphia, PA, United States
| |
Collapse
|